Hodgkin Lymphoma: An Update
| Autor: | Yazhen Zhong, Ellen Mullen |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Advanced and Specialized Nursing
medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Standard treatment Disease medicine.disease Radiation therapy Quality of life (healthcare) B symptoms Reed–Sternberg cell Health care Immunology medicine medicine.symptom business Intensive care medicine |
| Zdroj: | The Journal for Nurse Practitioners. 3:393-403 |
| ISSN: | 1555-4155 |
| DOI: | 10.1016/j.nurpra.2007.04.006 |
| Popis: | Hodgkin lymphoma (HL) is an uncommon neoplasm arising from B lymphocytes. It affects both men and women, young and old. A lot is yet to be learned about this disease even though it has been around for more than a century. HL is considered a curable disease. Recently, research has gained better understanding of its pathogenesis, which has opened ideas for development of new treatments. As of today, the standard treatment of HL is chemotherapy and involved-field radiation therapy. However, these treatments are sometimes not easily tolerated and can cause long-term side effects. The main goal of finding new treatments is to improve quality of life and to prevent long-term side effects. Health care providers can play an important role in caring for patients with HL through education, supportive care, and symptom management. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect